# NAPROXEN
> **ANDA212705** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2020-07-31
## Drug
- **FDA Application Number:** ANDA212705
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN
- **Generic name:** NAPROXEN
- **Active ingredients:** NAPROXEN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2020-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212705)
---
*AI Analytics · CC0 1.0*